Work

0740 Solriamfetol for Excessive Daytime Sleepiness in Narcolepsy and OSA: Post-hoc Multi-dimensional Composite Endpoint Analysis of Phase 3 Trials

Year: 2026

Type: conference-abstract

Source: SLEEP

DOI: 10.1093/sleep/zsag091.0739

Authors: Ellen Wermter, Sam Kashani, Graham Eglit, Samantha Floam, Robert Thomas

Institutions: University of California, Los Angeles, Axsome Therapeutics (United States), Beth Israel Deaconess Medical Center

Language: English

Topic: Sleep and Wakefulness Research

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7160641048

Cites:

Cited by:

Related to: